Andrew earned his BS in the dual major of Pharmacology & Toxicology from the Philadelphia College of Pharmacy and Science, now known as the University of Sciences in Philadelphia. Before joining Recursion, he worked for 15+ years at Merck & Co. in the Garden State of New Jersey. There, he spent most of his career doing such things as discovering a new class of antibiotics in platensimycin and demonstrating that non-coding RNA structural elements are suitable antibacterial targets as part of Merck's Department of Infectious Diseses. When not doing the whole science thing, Andrew likes spending time with his family, drawing, increasing the size of his comic book collection, and ring announcing for any independent professional wrestling organization that will give him the microphone.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.